Editors' ChoiceMEDICINE

Papers of note in Science Translational Medicine 9 (374)

See allHide authors and affiliations

Science Signaling  31 Jan 2017:
Vol. 10, Issue 464, eaam8627
DOI: 10.1126/scisignal.aam8627

This week’s papers describe therapies for myeloid cancers and a kinase to inhibit in order to prevent pathogenic bone destruction.


A new way to resorb bone

Andrade et al. report that inhibition of RON kinase prevents pathogenic bone destruction in mouse models and a human clinical study.


Stemming the tide of leukemia development

Chung et al. show that CD99 is a potential therapeutic target enriched on disease stem cells in myeloid malignancies.

CAR sharing

Qasim et al. report that universal gene-edited CAR19 T cells eliminate infant leukemia.

Highlighted Articles

Stay Connected to Science Signaling

Navigate This Article